Inhibikase Therapeutics | 4:持股变动声明-高管 Werner Milton H.
04/03 16:51 (美东)
Inhibikase Therapeutics | 4:持股变动声明-高管 Lees-Rolfe Garth
04/02 17:17 (美东)
Inhibikase Therapeutics | 3:首次持股声明-高管 Lees-Rolfe Garth
04/02 17:17 (美东)
Inhibikase Therapeutics | 4:持股变动声明-董事 BERMAN DENNIS N
2023/07/05 21:18 (美东)
Inhibikase Therapeutics | 4:持股变动声明-董事 Dion Gisele
2023/07/05 21:16 (美东)
Inhibikase Therapeutics | 4:持股变动声明-董事 GRINT PAUL C
2023/07/05 21:12 (美东)
Inhibikase Therapeutics | 4:持股变动声明-董事 Freeman Roy Lester
2023/07/05 21:11 (美东)
Inhibikase Therapeutics | 4:持股变动声明-高管 Werner Milton H.
2023/03/03 17:00 (美东)
Inhibikase Therapeutics | 4:持股变动声明-高管 FRATTAROLI JOSEPH
2023/03/03 17:00 (美东)
Inhibikase Therapeutics | SC 13D:超过5%持股股东披露文件-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)
2023/02/24 12:27 (美东)
Inhibikase Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Milton H. Werner(19.68%)
2023/02/15 19:45 (美东)
Inhibikase Therapeutics | D:发行公告
2023/02/07 16:48 (美东)
Inhibikase Therapeutics | SC 13D:超过5%持股股东披露文件-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)
2023/01/31 11:59 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/09/06 17:08 (美东)
Inhibikase Therapeutics | 3:首次持股声明-董事 Dion Gisele
2022/09/06 17:06 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/08/16 16:25 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/06/28 21:00 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/06/28 21:00 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/06/28 21:00 (美东)
Inhibikase Therapeutics | 4:持股变动声明
2022/06/28 21:00 (美东)
暂无数据
暂无数据